Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amanda R, Buckallew"'
Autor:
Jay R. Seltzer, Cameron Whitlock, Anastasia L. Armbruster, Amanda R. Buckallew, William Miller, Gina Mbachu, Rachel Watson, Katie B. Tellor
Publikováno v:
European Journal of Clinical Pharmacology. 77:955-960
Spironolactone reduces morbidity and mortality in patients with heart failure (HF) with reduced ejection fraction (EF) and decreases hospitalizations in HF with preserved EF. To minimize the risk of hyperkalemia, patients must have an estimated glome
Autor:
Amanda R, Buckallew, Katie B, Tellor, Rachel, Watson, William, Miller, Gina, Mbachu, Cameron, Whitlock, Jay R, Seltzer, Anastasia L, Armbruster
Publikováno v:
European journal of clinical pharmacology. 77(7)
Spironolactone reduces morbidity and mortality in patients with heart failure (HF) with reduced ejection fraction (EF) and decreases hospitalizations in HF with preserved EF. To minimize the risk of hyperkalemia, patients must have an estimated glome
Publikováno v:
Hospital pharmacy. 52(9)
Background: Enoxaparin, a low-molecular-weight heparin approved for prophylaxis in patients at risk for venous thromboembolism (VTE), offers several advantages compared with unfractionated heparin (UFH). Enoxaparin is primarily excreted through renal
Publikováno v:
Journal of Pharmacy Technology; Aug2024, Vol. 40 Issue 4, p171-177, 7p
Publikováno v:
Cardiovascular Week; 5/14/2024, p934-934, 1p
Autor:
Buckallew, Amanda R., Tellor, Katie B., Watson, Rachel, Miller, William, Mbachu, Gina, Whitlock, Cameron, Seltzer, Jay R., Armbruster, Anastasia L.
Publikováno v:
European Journal of Clinical Pharmacology; Jul2021, Vol. 77 Issue 7, p955-960, 6p, 3 Charts